human placenta; trophoblast; monocarboxylic acid L-LACTIC ACID IS UTILIZED as a metabolic energy source in a variety of fetal tissues, such as porcine fetal heart (30) , rat fetal brain (3) , and ovine fetal liver (10b) . Moreover, L-lactic acid is considered to be one of the major carbon sources for fatty acid synthesis, as demonstrated in fetal calves. In humans, the blood level of L-lactic acid in the fetal circulation is higher than in the maternal circulation (19) , suggesting that L-lactic acid is also essential for growth of the human fetus.
L-Lactic acid is a monocarboxylic acid (pK a 3.86) that is mostly ionized under physiological conditions. Because the ionized form is not expected to permeate well, a carrier-mediated process is considered to be involved in the permeation of L-lactic acid across the plasma membranes. The transport of L-lactic acid has been well investigated, especially in human erythrocytes, and is ascribed mainly to an H ϩ -dependent system and partly to an anion exchange system (8) . In other tissues such as hepatocytes, intestinal brushborder membranes, and skeletal muscles, L-lactic acid was also reported to be transported in an H ϩ -dependent manner (20, 22, 27) . On the other hand, L-lactic acid-Na ϩ cotransport was shown to occur at the renal brush-border membrane (4) , and an anion exchange system is involved in L-lactic acid transport in the jejunal basal membrane. Intratissue heterogeneity of the functional properties for L-lactic acid transport was also demonstrated in rat medullary thick limbs of Henle, where the characteristics of L-lactic acid transport in the basal membrane are different from those in the brush-border membrane, i.e., H ϩ cotransport in the basolateral membrane and organic anion exchange in the brush-border membrane (10) . Thus, to fully understand the L-lactic acid transport mechanism across polarized cells, the transport mechanism at each membrane should be separately characterized.
Maternal and fetal circulations are separated by villous tissue in the placenta. The trophoblast, the functional unit of villous tissue, is considered to be the functional entity of the placental barrier. The trophoblast cell consists of brush-border membrane on the maternal side and basal membrane on the fetal side, and it regulates the exchange of various materials, such as nutrients, between mother and fetus. In the brush-border membrane of the trophoblast, H ϩ gradient-dependent L-lactic acid transport was found to occur (1, 5, 18) . In the basal membrane, however, a limited study indicated that an overshoot phenomenon occurs in the presence of an inwardly directed H gradient (2) . The purpose of the present study was to characterize the transport system of L-lactic acid at the basal membrane of the trophoblast compared with that at the brush-border membrane, which we investigated previously (18) , by using membrane vesicles prepared from human placentas.
MATERIALS AND METHODS

Chemicals. L-[U-
14 C]lactic acid (116 mCi/mmol) was purchased from INC Biomedicals (Costa Mesa, CA), L- [2, H]alanine (52 Ci/mmol) was from Amersham International (Little Chalfont, UK), and [ 3 H]dihydroalprenolol (DHA; 31 mCi/mmol) was from NEN Life Science Products (Boston, MA). Acetic acid, L-and D-lactic acid, propionic acid, pyruvic acid, succinic acid, and glutaric acid were purchased from Nacalai Tesque (Kyoto, Japan). ␣-Cyano-4-hydrocinnamate (4-CHC), 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS), and phloretin were purchased from Sigma Chemical (St. Louis, MO). p-Chloromercuribenzenesulfonate (pCMBS) was from both Sigma Chemical and Nacalai Tesque. All other chemicals were of reagent grade.
Preparation of basal membrane vesicles and brush-border membrane vesicles of human placental trophoblast. Basal membrane vesicles (BLMVs) of human term placental trophoblast were prepared by the method previously described by Eaton and Oakey (9) with minor modifications. All operations were carried out at 4°C. Normal human term placentas from uncomplicated pregnancies were obtained within 15 min after vaginal or cesarean delivery and placed in 0.9% NaCl at 4°C. After the cord, amniochorion, and decidua were removed, the placental tissue was cut into pieces and villous tissue was collected. The tissue was washed, stirred in phosphate-buffered saline (PBS) for 30 min, and collected on a 250-m-pore size nylon mesh. The tissue was washed three times with cold buffer A (50 mM Tris ⅐ HCl, pH 7.4), collected on a nylon mesh, and divided into 15-g portions. Each portion was sonicated in 100 ml of buffer A for 10 s at 90% maximum amplitude with the use of a sonicator (Vibra-cell VCX400; Sonics and Materials, Newtown, CT). Sonicated tissue was collected on the mesh, washed three times with buffer B (5 mM Tris ⅐ HCl, pH 7.4), and then stirred gently for 60 min in 5ϫ buffer B. The tissue was collected on the nylon mesh and washed three times with buffer B. Tissue portions of 18-20 g were resuspended in 100 ml of buffer C (50 mM Tris ⅐ HCl, pH 7.4, containing 10 mM EDTA and 250 mM sucrose) and incubated for 30 min with occasional stirring. The portions were then sonicated four times for 10 s at 100% maximum amplitude. Suspensions were strained through the nylon mesh, and the supernatant was centrifuged at 3,430 g for 10 min. The supernatant from this spin was recentrifuged at 80,000 g for 40 min to yield the pellet, which was resuspended in ϳ12 ml of buffer D (25 mM HEPES-Tris, pH 7.4, containing 1 mM EDTA and 275 mM sucrose) using a homogenizer (Mini D.C. Stirrer; Eyela, Tokyo, Japan). This fraction was designated as crude basal membrane fraction and further purified by centrifugation on a discontinuous Ficoll gradient. Ficoll in the resuspension buffer (10%, wt /vol) was overlaid with 4% Ficoll, and resuspended materials at the top were centrifuged at 90,000 g for 6-8 h. The material at the 4-10% interface was collected and diluted approximately fivefold with buffer D. The pellet (BLMVs) was resuspended in buffer E (25 mM HEPES-Tris, pH 7.4, containing 275 mM sucrose) and passaged through a 25-gauge syringe needle six times. BLMVs were quickly frozen and stored at Ϫ80°C for up to 1 mo until use.
Tissue homogenate was prepared by the method previously described by Kelley et al. (15) . Approximately 3 g of whole villous tissue were homogenized in 10 ml of buffer E by using a Glass Teflon homogenizer (Physcotron; Micro Teq Nichion, Chiba, Japan) for 2.25 min and further with a homogenizer for eight strokes. The material was filtered through six layers of gauze.
Brush-border membrane vesicles (BBMVs) of human placental trophoblast were prepared by the method previously described by Nakamura et al. (18) .
Purity and orientation of BLMVs and BBMVs. Binding activity of DHA as a marker of the basal membrane and alkaline phosphatase (ALP) activity as a marker of the brush-border membrane were assayed as reported by Kelley et al. (15) and Bessey et al. (5a) , respectively. P-glycoprotein (P-gp) was also quantitated as a marker of brush-border membrane to assess the purity of BBMVs and BLMVs, because P-gp has been reported to exist only on the brushborder membrane of trophoblast (25) . P-gp was quantitated by using Western Blotting with the quantitation software Quantity One (Bio-Rad Laboratories, Hercules, CA). Protein was quantified by the method of Lowry et al. (17) using bovine serum albumin as a standard.
An orientation assay for BLMVs was carried out with the use of concanavalin A-fluorescein as described by Illsley et al. (13) . BBMV orientation was determined by measuring nucleotide pyrophosphatase activity (6) .
Uptake measurements. The uptake of L-[ To investigate the concentration-dependent uptake or the effect of inhibitors, unlabeled L-lactic acid or inhibitor was added to this incubation buffer. At the designated time, uptake was terminated by adding 1 ml of ice-cold stop solution, followed immediately by filtration (HAWP 0.45 m; Millipore Intertech, Bedford, MA). The filter was washed twice with 4 ml of ice-cold stop solution. Stop solution contained, in general, 100 M L-alanine or 1 mM L-lactic acid and 10 mM sucrose in EM buffer. Nonspecific binding was determined by adding 1 ml of ice-cold stop solution and 40 l of ice-cold incubation buffer to the ice-cold BLMV suspension, followed by the same treatment as in the uptake experiments.
To assay the radiolabeled compounds, filters were put into counting vials and mixed with 4 ml of scintillation fluid, Clear-sol I (Nacalai Tesque). Radioactivity was determined using a liquid scintillation counter (LS6500; Beckman Instruments, South Pasadena, CA).
Uptake into BBMVs was determined by the method described by Nakamura et al. (18) .
Data analysis. Obtained radioactivity was normalized with respect to the protein amount of vesicles. Data are presented as ratio of vesicle to medium, obtained by dividing the uptake amount by the drug concentration (l/mg protein), or uptake coefficient (l ⅐ mg protein Ϫ1 ⅐ 5 s Ϫ1 ). Values were determined by subtracting the nonspecific binding from total uptake, except in the investigation of osmolarity effects.
To determine the kinetic parameters Km, Jmax, and kd for the L-lactic acid uptake, data were fitted to the following Michaelis-Menten equation by using nonlinear least-squares regression analysis (MULTI; Ref. 32) where J and S represent the transport rate and concentration of substrate, respectively. J max (nmol ⅐ mg protein Ϫ1 ⅐ 5 s Ϫ1 ), Km (mM), and kd (l ⅐ mg protein Ϫ1 ⅐ 5 s Ϫ1 ) represent the maximum uptake rate for a carrier-mediated process, the Michaelis constant, and the rate constant for the nonsaturable component, respectively.
Statistical analysis. Statistical analysis was performed by using Student's t-test or ANOVA followed by Duncan's test. Differences between means were considered to be significant when the P value was Ͻ0.05. , amounting to threefold enrichment over the homogenate (0.565 Ϯ 0.066 mol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 ). The amounts of protein in BLMVs and homogenate obtained from 100 g of placental tissue were 2.62 Ϯ 0.20 and 2890 Ϯ 91 mg, respectively, showing that 0.091% of the homogenate was recovered as BLMVs. The level of P-gp in BBMVs was 22-fold higher than in BLMVs (Fig. 1) . The ratio of right-side-out BLMVs was 89.6%, whereas 41.9% of BBMVs were right-side-out (Table 1) .
RESULTS
Purity and orientation of BLMVs and BBMVs of human placental trophoblast.
Functional validation of BLMVs. Functional activity of BLMVs was evaluated in terms of the Na ϩ -dependent uptake of L-alanine. Time courses of the uptake of 100 M L-[ 3 H]alanine into BLMVs in the presence of 45 mM Na ϩ and K ϩ are shown in Fig. 2 . The uptake of L-alanine was significantly stimulated in the presence of an inwardly directed Na ϩ gradient compared with the K ϩ gradient.
Effect of Na
ϩ gradient on the uptake of L-lactic acid. Figure 3 shows the uptakes of 1 mM L-[
14 C]lactic acid into BLMVs in the presence of inwardly directed Na ϩ and K ϩ gradients. The initial uptake rates were almost identical, and no Na ϩ dependency of L-lactic acid transport was observed in basal membrane. Figure 4 shows the time courses of the uptake of 1 mM
Effect of pH gradient on the uptake of L-lactic acid.
14 C]lactic acid into BLMVs at extravesicular pH 5.5 and 7.4. When the intravesicular pH was fixed at pH 7.4, the uptake of L-lactic acid into BLMVs was enhanced, and transient uphill transport was observed at extravesicular pH 5.5. The initial uptake rate at pH 5.5 was ninefold higher than that at pH 7.4 when assessed at 30 s. The uptake of L-[
14 C]lactic acid was markedly stimulated by extravesicular acidification and was significantly suppressed in the presence of 100 mM unlabeled L-lactic acid (Fig. 5) . Enrichment is the ratio of marker activity in the basal membrane vesicles (BLMVs) or brush-border membrane vesicles (BBMVs) to that in homogenate or crude brush-border membrane. Dihydroaloprenolol (DHA) binding is a marker for basal membrane, and alkaline phosphatase is a marker enzyme for brush-border membrane. P-glycoprotein was present in BBMVs but not in BLMVs. BLMVs were 90% right-side-out, whereas 42% of BBMVs were right-side-out. Each value presents the mean Ϯ SE of 3 or 4 experiments. * Data cited from our previous report (18) . Fig. 1 . Immunodetection of P-glycoprotein (P-gp). Protein samples, human placental brush-border membrane vesicles (BBMVs; 50 g), and human placental basolateral membrane vesicles (BLMVs; 50 g) were resolved by SDS-PAGE on 7.5% polyacrylamide gel and transferred onto Clear Blot Membrane-P (Atto, Tokyo, Japan). A: immunoblots were performed with anti-P-gp mouse monoclonal antibody C219 (TFB, Tokyo, Japan) and developed with the enhanced chemiluminescence detection reagent (ECL; Amersham, Oakville, ON, Canada), as described in a recent report (29) . B: P-gp was quantitated by using Western blotting with the quantitation software Quantity One. Table 2 shows the results in BLMVs, along with our previous results for BBMVs (18) . The initial uptake of L-lactic acid into BLMVs was inhibited by pCMBS and 4-CHC in a concentration-dependent manner but was not affected by phloretin or DIDS. In contrast, the uptake into 14 C]lactic acid in the presence of a pH gradient. The uptake of L-lactic acid was performed in the presence of various concentrations of sucrose. Each data point represents the mean Ϯ SE of 3 experiments. Significant differences from the control were identified by using Student's t-test (*P Ͻ 0.05).
Kinetics of the initial uptake of
BBMVs was inhibited by all of the inhibitors investigated.
Effects of mono-and dicarboxylic acids on the uptake of L-lactic acid. Table 3 shows the effects of mono-and dicarboxylic acids on the uptakes of 1 mM L-[
14 C]lactic acid into BLMVs and BBMVs in the presence of a pH gradient, including data from our previous report on BBMVs (18) . Monocarboxylic acids (acetic acid, L-lactic acid, D-lactic acid, propionic acid, and pyruvic acid) and 4) . The uptake of 1 mM L-lactic acid into BLMVs was performed at 37°C for 5 s in the buffer containing various inhibitors in the presence of 0.5% dimethylsulfoxide (DMSO) [except for P-chloromercuribenzenesulfonate (pCMBS)], 25 mM MES-Tris (pH 5.5), and sucrose. Each value represents the mean Ϯ SE of 9 experiments. Significant differences from control were determined by using ANOVA followed by Duncan's test ( †P Ͻ 0.05). The control value in the absence of DMSO was 3.05 Ϯ 0.17 l/mg protein, whereas that in the presence of 0.5% DMSO was 2.57 Ϯ 0.19 l/mg protein. *Data cited from our previous report (18) . 4-CHC, ␣-cyano-4-hydroxycinnamate. BLMVs were preloaded with 275 mM sucrose and 25 mM HEPESTris (pH 7.4). The uptake of 1 mM L-lactic acid into BLMVs was performed at 37°C for 5 s in the buffer containing various inhibitors, 25 mM MES-Tris (pH 5.5), and sucrose. BBMVs were preloaded with 250 mM mannitol and 10 mM HEPES-Tris (pH 7.4). The uptake of 1 mM L-lactic acid into BBMVs was performed at 37°C for 5 s in the buffer containing various inhibitors, 10 mM MES-Tris (pH 5.5), and mannitol. Each value represents the mean Ϯ SE of 3 or 4 experiments. Significant differences from control were determined by using ANOVA followed by Duncan's test ( †P Ͻ 0.05). The control value for BLMVs was 3.52 Ϯ 0.32 l/mg protein, whereas that for BBMVs was 3.25 Ϯ 1.63 l/mg protein. * Data cited from our previous report (18) . dicarboxylic acids (succinic acid and glutaric acid) all suppressed the uptake of L-lactic acid in a concentration-dependent manner. With regard to BLMVs, all the carboxylic acids at high concentration (50 mM) suppressed the uptake, whereas only L-and D-lactic acid inhibited the uptake at low concentration (5 mM). There was no statistically significant difference in the inhibition of the uptake of L-lactic acid between L-and D-lactic acid, suggesting that the inhibitory effect of lactic acid is not stereoselective.
DISCUSSION
Characteristics of BLMVs. In this study, we initially assessed the binding of DHA, a marker for basal membrane, and the enzymatic activity of ALP, a marker for brush-border membrane, to confirm the purity of BLMVs isolated from human placental syncytiotrophoblast. The enrichment of DHA binding was 32-fold, considerably higher than that of ALP activity, which was only threefold (Table 1) . It has been reported that the enrichment of DHA binding and ALP activity were 18.5-to 45.0-fold and 0.60-to 5.01-fold, respectively (9, 10a, 12, 15, 17a, 17b, 24a) . Our results fall within the above ranges and indicate that the basal membrane was selectively recovered. Moreover, we demonstrated that P-gp was expressed only in the BBMVs, not in the BLMVs (Fig. 1) . The absence of P-gp in the BLMVs also indicates that the contamination of brush-border membrane in the BLMVs is negligible. The orientation of BLMVs, assessed by the use of concanavalin A, was 90% right-side-out. Na ϩ -dependent uptake of L-alanine was observed (Fig. 2) , as expected (12) . The uptake of L-alanine declined with increase in the osmolarity of external buffer (Fig. 2) , suggesting that L-alanine was not only adsorbed onto vesicles but actually transported into the intravesicular space. Therefore, BLMVs prepared in this study should be a suitable model to elucidate the characteristics of transport across the basal membrane of the human placental syncytiotrophoblast.
Mechanism of L-lactic acid uptake into BLMVs. In the presence of a pH gradient, the uptake of L-lactic acid into BLMVs showed an overshoot phenomenon (Fig. 4) , i.e., L-lactic acid was transiently accumulated inside the vesicles against the concentration gradient. The uptake of L-lactic acid at the steady state was reduced with increase in the osmolarity of the external buffer (Fig. 4) , suggesting that L-lactic acid was not only adsorbed onto the surface of vesicles but also transported into the vesicles. The initial uptake rate of L-lactic acid increased with decrease in the extravesicular pH (Fig. 5) . Although the simple diffusion of L-lactic acid, a monocarboxylic acid with a pK a of 3.86, increased at lower pH, the uptake of L-[
14 C]lactic acid in the presence of 100 mM L-lactic acid did not show pH dependency. Therefore, a pH-dependent transport system was demonstrated to be involved in the uptake of L-lactic acid, in addition to simple diffusion. pCMBS and 4-CHC, which are known to interact with H ϩ -linked L-lactic acid carriers, reduced the uptake of L-lactic acid into BLMVs in the presence of a pH gradient (Table 2 ). These results indicate that a H ϩ gradient-dependent carrier for L-lactic acid exists on the basal membrane of human placental trophoblast.
Comparison of the uptake properties of L-lactic acid between BLMVs and BBMVs of human placental trophoblast. In BBMVs of human placental trophoblast, L-lactic acid was reported to be transported in an Na ϩ -independent and H ϩ -dependent manner (5). This is consistent with our present findings (Figs. 3-5) . The uptake properties of L-lactic acid into BLMVs were similar to those into BBMVs in many respects: the uptake was saturable, H ϩ gradient dependent, and inhibited by mono-and dicarboxylic acids including D-lactic acid (Fig. 6 and Table 3 ). The K m value for L-lactic acid in BLMVs was determined to be 5.89 mM (Table 4) , which is close to the K m value in BBMVs [1.71 mM (18) and 4.1 mM (5)]. Therefore, brushborder and basal membranes in the human placental trophoblast may share common functional properties for the transport of L-lactic acid. However, the inhibitory effects of pCMBS, 4-CHC, and acetic acid in BLMVs were weaker than those in BBMVs, and phloretin and DIDS were ineffective in BLMVs (Tables 2  and 3) . Therefore, the H ϩ -dependent transport system for L-lactic acid in basal membrane seems to differ in some respects from that in brush-border membrane.
Physiological implications. The physiological concentration of L-lactic acid in the fetal circulation was reported to be ϳ2 mM (19) , whereas the K m value of L-lactic acid transport in the basal membrane was 5.89 mM, which implies that this transport system may be functional under physiological conditions.
Fetal blood is slightly more acidic (pH 7.3) than maternal blood (pH 7.4) (19) . In addition, an Na ϩ /H ϩ exchanger (NHE-2) exists on the basal membrane of human placental syncytiotrophoblast and generates a local H ϩ gradient across the membrane. This H ϩ gradient would provide a driving force for L-lactic acid transport across the trophoblast basal membrane. Taking into consideration the direction of the H ϩ gradient under physiological conditions and the orientation of the prepared BLMVs, the direction of uptake observed in this study corresponds to the transfer of L-lactic acid from fetus to mother. Accumulation of L-lactic acid in the fetus can cause damage to the heart and cerebral tissue during hypoxia and induces acidosis in the fetus. Therefore, the L-lactic acid transport system in the basal membrane may help to prevent excessive increase of L-lactic acid in the fetus. The lower affinity for L-lactic acid on the fetal side compared with the maternal side of the trophoblast is consistent with this hypothesis. Indeed, at the end of gestation, L-lactic acid produced in human fetus is transferred to the placenta (19) . On the other hand, the fetus utilizes L-lactic acid for metabolic energy and for fatty acids synthesis. L-Lactic acid in the maternal circulation or produced in the placenta by glycolysis might be transferred to the fetus under certain conditions. Indeed, L-lactic acid can be transported in both directions by the same carrier under certain circumstances in rat BBMVs (1), sup-porting the idea that the transport system observed in this study in BLMVs may possibly transfer L-lactic acid bidirectionally across the placenta. At any rate, transporters in the brush-border and basal membranes of placental trophoblast may cooperatively regulate the fetal concentration of L-lactic acid.
Comparison with other tissues. In the brush-border membrane of kidney cortex, Na ϩ -L-lactic acid cotransport is a major mechanism for the transport of L-lactic acid (4) . The lack of Na ϩ -dependency in human trophoblast BLMVs (Fig. 2) indicates that the L-lactic acid transport system in basal membrane of trophoblast is distinct from that in brush-border membrane of kidney cortex.
An H ϩ gradient-dependent transport of L-lactic acid has also been observed in the plasma membrane of other mammalian tissues. As summarized in Table 4 , the K m value was similar to that in the small intestinal BBMVs [12.7 mM (27) pCMBS, an irreversible inhibitor, has been demonstrated to specifically inhibit H ϩ -linked L-lactic acid transport in erythrocytes (8), whereas 4-CHC is a reversible inhibitor for H ϩ -linked transporters (20) . The uptake of L-lactic acid into BLMVs of placental trophoblast in the presence of an H ϩ gradient was reduced by 10 mM pCMBS and 12.5 mM 4-CHC by only 19 and 27%, respectively (Table 2) , whereas in porcine large intestinal BBMVs, lower concentrations of pCMBS (0.5 mM) and 4-CHC (5 mM) have been reported to reduce the transport by 83 and 69%, respectively (22) . In rat skeletal muscle vesicles, 0.5 mM pCMBS and 10 mM 4-CHC inhibit the uptake by 83 and 69%, respectively (23) . Therefore the transport system for L-lactic acid in BLMVs of placental trophoblast appears to be less sensitive to these inhibitors (Table 4) . These variations may be due to tissue and/or species differences.
Phloretin, a reversible inhibitor, has been reported to decrease L-lactic acid transport in a variety of mammalian epithelial cells (20) . In contrast, the H ϩ -L-lactic acid cotransporter in the basal membrane of rat medullary thick limbs of Henle was reported to be insensitive to phloretin (10) ( Table 4) . In this study, the transport of L-lactic acid in the basal membrane of placental trophoblast was not inhibited by phloretin and is therefore similar to that in the basal membrane of rat medullary thick limbs of Henle.
The anion exchange system (Cl Ϫ /HCO 3 Ϫ exchanger), which is potently inhibited by DIDS, is an another candidate for L-lactic acid uptake in erythrocytes (8) . However, the intravesicular or extravesicular buffer did not contain any driving force for an anion exchanger, bicarbonate or chloride, under our experimental conditions, so the anion exchanger is not expected to have contributed to the uptake of L-lactic acid. Moreover, the expression level of anion exchanger (AE1) in basal membrane of human placental syncytiotrophoblast has been reported to be low. Consequently, the anion exchange mechanism may make little contribution to the transport of L-lactic acid. The inhibitory effect of D-lactic acid was not significantly different from that of L-lactic acid in the presence of an H ϩ gradient (Table 3) . However, the stereoselective transport of lactic acid has been reported in the skeletal muscle (23) and the liver (20) but not in the cardiac muscle (28) (Table 4) . Hence, in this respect, L-lactic acid transport in the basal membrane of placental trophoblast is different from that in skeletal muscle or liver and similar to that in cardiac muscle.
Dicarboxylic acids such as succinic acid and glutaric acid were found to reduce the uptake of L-lactic acid into BLMVs in the presence of an H ϩ gradient, with comparable inhibitory potency to that of monocarboxylic acids (Table 3) . These results are in contrast with the transport properties of L-lactic acid in many other tissues, where the transport is inhibited by monocarboxylic acids but not by dicarboxylic acids (20) . However, the inhibition of L-lactic acid transport by dicarboxylic acids was demonstrated in rabbit small intestinal BBMVs (26) ( Table 4 ). The nature of the inhibition by dicarboxylic acids remains to be evaluated.
Relationship to monocarboxylic acid transporters. Several monocarboxylic acid transporters (MCTs), which transport monocarboxylic acids including L-lactic acid, have been cloned. The presence of mRNAs of MCT1, -2, -4, -5, -6, -7, and -8 was confirmed in human placenta (21) , and MCT4 protein was also detected by Western blotting (31) . Functional analyses have mainly dealt with MCT1, -2, -3, and -4. Broer et al. (7) reported that L-lactic acid transport via rat MCT1 and MCT2 was H ϩ dependent and inhibited by 4-CHC and monocarboxylic acids, and rat MCT1 was also sensitive to pCMBS. In addition, the K m values of human MCT1 and MCT2 for the transport of L-lactic acid were determined to be 6.0 and 6.5 mM, respectively (16) . The present results show some similarities, including H ϩ -dependency, sensitivity to pCMBS and 4-CHC, and K m value, suggesting that MCTs may transport L-lactic acid across the basal membrane of trophoblast. The uptake of L-lactic acid into BLMVs of trophoblast was inhibited by pCMBS and 4-CHC but not by phloretin, an inhibitor for rat MCT1 (7) . pCMBS inactivates rat MCT1 without affecting MCT2 activity (7). Chick MCT3 was reported to be resistant to pCMBS, 4-CHC, and phloretin (11) . These reports suggest that each isoform of MCTs may possess a distinct sensitivity to inhibitors. None of the known isoforms seems to show L-lactic acid transport properties identical with those observed in this study. Therefore, the transport of L-lactic acid across the basal membrane of placental trophoblast may be mediated by an as yet uncharacterized MCT isoform(s).
In conclusion, the basal membrane of human term placental trophoblast possesses an H ϩ -dependent L-lactic acid transport system whose properties are similar to those of MCTs and lacks an Na ϩ -dependent transport system. In addition, the characteristics of the L-lactic acid transport in the basal membrane are similar to those in the brush-border membrane. However, the difference in the sensitivity of H ϩ -dependent L-lactic acid transport to phloretin and DIDS between the basal and the brush-border membranes implies that distinct transporters of L-lactic acid may exist on each side of the trophoblast.
